Dongmei Zhang1, Jinmei Luo1, Yixian Qiao1, Yi Xiao1. 1. Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Abstract
BACKGROUND: Although continuous positive airway pressure (CPAP) has become the first line of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy patients could benefit from CPAP treatment. METHODS: We searched the online databases Medline, Embase, the Cochrane library and the Cochrane Central Registry of Controlled Trials to select eligible control trials, including non-sleepy OSA patients and those patients treated by CPAP or either sham CPAP or no CPAP. RESULTS: Seven eligible studies (1,541 patients) were included. The pooled estimates of the mean changes after CPAP treatment for the systolic blood pressure (SBP) and diastolic blood pressure (DBP) were -0.51 mmHg (95% CI, -3.39 to 2.38 mmHg; P=0.73) and -0.92 mmHg (95% CI, -1.39 to -0.46 mmHg; P<0.001), respectively. CPAP should not improve subjective sleepiness in the minimally symptomatic OSA patients, as the change in the Epworth sleepiness scale (ESS) was -0.51 (95% CI, -1.68 to 0.67; P=0.397). However, CPAP can effectively reduce AHI or ODI by 15.57 events/h (95% CI, -29.32 to -1.82; P=0.026) compared to controls. However, the risk of cardiovascular events did not significantly decrease [odds ratio (OR), 0.80; 95% CI, 0.50 to 1.26; P=0.332] in the end. CONCLUSIONS: CPAP treatment can reduce OSA severity in non-sleepy patients and minutely reduce the DBP, but CPAP seems to have no overall beneficial effects on subjective sleepiness, SBP, or cardiovascular risk.
BACKGROUND: Although continuous positive airway pressure (CPAP) has become the first line of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy patients could benefit from CPAP treatment. METHODS: We searched the online databases Medline, Embase, the Cochrane library and the Cochrane Central Registry of Controlled Trials to select eligible control trials, including non-sleepy OSA patients and those patients treated by CPAP or either sham CPAP or no CPAP. RESULTS: Seven eligible studies (1,541 patients) were included. The pooled estimates of the mean changes after CPAP treatment for the systolic blood pressure (SBP) and diastolic blood pressure (DBP) were -0.51 mmHg (95% CI, -3.39 to 2.38 mmHg; P=0.73) and -0.92 mmHg (95% CI, -1.39 to -0.46 mmHg; P<0.001), respectively. CPAP should not improve subjective sleepiness in the minimally symptomatic OSA patients, as the change in the Epworth sleepiness scale (ESS) was -0.51 (95% CI, -1.68 to 0.67; P=0.397). However, CPAP can effectively reduce AHI or ODI by 15.57 events/h (95% CI, -29.32 to -1.82; P=0.026) compared to controls. However, the risk of cardiovascular events did not significantly decrease [odds ratio (OR), 0.80; 95% CI, 0.50 to 1.26; P=0.332] in the end. CONCLUSIONS: CPAP treatment can reduce OSA severity in non-sleepy patients and minutely reduce the DBP, but CPAP seems to have no overall beneficial effects on subjective sleepiness, SBP, or cardiovascular risk.
Authors: Yasaman Djavadkhani; Nathaniel S Marshall; Angela L D'Rozario; Megan R Crawford; Brendon J Yee; Ronald R Grunstein; Craig L Phillips Journal: Thorax Date: 2015-01-16 Impact factor: 9.139
Authors: Ferran Barbé; Joaquín Durán-Cantolla; Francisco Capote; Monica de la Peña; Eusebi Chiner; Juan F Masa; Mónica Gonzalez; Jose M Marín; Francisco Garcia-Rio; Josefa Diaz de Atauri; Joaquín Terán; Mercedes Mayos; Carmen Monasterio; Felix del Campo; Sivia Gomez; Manuel Sanchez de la Torre; Montse Martinez; José M Montserrat Journal: Am J Respir Crit Care Med Date: 2009-12-10 Impact factor: 21.405
Authors: Malcolm Kohler; Sonya Craig; Justin C T Pepperell; Debby Nicoll; Daniel J Bratton; Andrew J Nunn; Paul Leeson; John R Stradling Journal: Chest Date: 2013-09 Impact factor: 9.410
Authors: M Alajmi; A T Mulgrew; J Fox; W Davidson; M Schulzer; E Mak; C F Ryan; J Fleetham; P Choi; N T Ayas Journal: Lung Date: 2007-03-28 Impact factor: 2.584
Authors: Imran H Iftikhar; Christopher W Valentine; Lia R A Bittencourt; Debbie L Cohen; Annette C Fedson; Thorarinn Gíslason; Thomas Penzel; Craig L Phillips; Lin Yu-sheng; Allan I Pack; Ulysses J Magalang Journal: J Hypertens Date: 2014-12 Impact factor: 4.844
Authors: Maria Alexandra Mineiro; Pedro Marques da Silva; Marta Alves; Ana Luísa Papoila; Maria João Marques Gomes; João Cardoso Journal: BMC Pulm Med Date: 2017-12-08 Impact factor: 3.317